Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254

Thrombosis and Haemostasis

Volumn 79, Issue 1, 1998, Pages 186-194

  DeLa Cadena, Raul A ^a   Kunapuli, Satya P ^a   Walz, Daniel A ^b   Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; HIGH MOLECULAR WEIGHT KININOGEN; IODINE 125; KININOGEN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; THROMBIN; THROMBOSPONDIN 1;

ALKYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION;

EID: 0031974828     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614248     Document Type: Article

References (46)

1. Kitamura N, Kitagawa H, Fukushima D, Takagaki Y, Miyata T. Nakanishi S. Structural organization of the human kininogen gene and a model for its evolution. J Biol Chem 1985; 260: 8610-7.
2. Salvesen G, Parkes C, Abrahamson M, Grubb A, Barrett AJ. Human low molecular weight kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem J 1986; 234: 429-34.
3. Gustafson EJ, Schutsky D, Knight LC, Schmaier AH. High molecular weight kininogen binds to unstimulated platelets. J Clin Invest 1986; 78: 310-8.
4. Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem 1991; 266: 6786-94.
5. Puri RN, Zhou F, Hu C-J, Colman RF, Colman RW. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibitory binding of thrombin to platelets. Blood 1991; 77: 500-7.
6. Jiang YP, Müller-Esterl W, Schmaier AH. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation. J Biol Chem 1992; 267: 3712-7.
7. Kunapuli SP, Bradford HL, Jameson BA, DeLa Cadena RA, Rick L, Wassel RP, Colman RW. Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 domain 3 in the heavy chain of high molecular weight kininogen. J Biol Chem 1996; 271: 11228-34.
8. DeLa Cadena RA, Colman RW. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. Protein Sci 1992; 1: 151-60.
9. Meloni FJ, Gustafson EJ, Schmaier AH. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood 1992; 79: 1233-44.
10. Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971; 68: 240-3.
11. Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 1986; 103: 1635-48.
12. Hennessy SW, Frazier BA, Kim DD, Deckwerth TL, Baumgartel DM, Rotwein P, Frazier WA. Complete thrombospondin mRNA sequence includes potential regulatory sites in the 3′ untranslated region. J Cell Biol 1989; 108: 729-36.
13. Bornstein P, Alfi D, Devarayalu L, Framson P, Li P. Characterization of the mouse thrombospondin gene and evaluation of the role of the first intron in human gene expression. J Biol Chem 1990; 265: 16691-8.
14. Dixit VM, Grant GA, Santoro SA, Frazier WA. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem 1984; 259: 10100-5.
15. Prochownik EV, O'Rourke K, Dixit VM. Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule. J Cell Biol 1989; 109: 843-52.
16. Goundis D, Reid KBM. Properdin, the terminal complement components, thrombospondin and the circum sporozoite protein of malaria parasites contain similar sequence motifs. Nature (London) 1988; 335: 82-5.
17. Prater CA, Plotkin J, Jaye D, Frazier WA. The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J Cell Biol 1991; 112: 1031-40.
18. Lawler J, Simons ER. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J Biol Chem 1983; 258: 12098-3001.
19. Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombospondin. The role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 1988; 107: 23551-61.
20. DeLa Cadena RA, Wyshock EG, Kunapuli SP, Schultze RL, Miller M, Walz DA, Colman RW. Platelet thrombospondin interactions with human high and low molecular weight kininogens. Thromb Haemost 1994; 72: 125-31.
21. Herwald H, Hasan AAK, Godovac-Zimmermann J, Schmaier AH, Müller-Esterl W. Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem 1985; 270: 14634-42.
22. DeLa Cadena RA, Bradford HN, Kunapuli SP, Colman RW. The platelet binding site on the heavy chains of human high (HK) and low (LK) molecular weight kininogens is confined to residues Lys244-Pro254. Thromb Haemost 1993; 69: 781.
23. Scott CF, Whitaker EJ, Hammond BF, Colman RW. Purification and characterization of a potent 70 kDa thiol lysyl proteinase (lys-gingivain) from phorphoryromas gingivalis. J Biol Chem 1993; 268: 2486-92.
24. Bacon-Baguley T, Kudrik BJ, Walz DA. Thrombospondin interactions with fibrinogen. J Biol Chem 1987; 262: 1927-30.
25. Lawler JW, Slayter HS, Colligan JE. Isolation and characterization of a high molecular weight kininogen glycoprotein from human blood platelets. J Biol Chem 1987; 283: 8609-16.
26. Fraker PC, Speck SC, Jr. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α6α-diphenyl-glycouril. Biochem Biophys Res Commun 1987; 80: 849-57.
27. Laemmli UK. Cleavage of the structural proteins during assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-5.
28. Glantz SA. The special case of two groups: the t test. In: Primer of Biostatistics: The Program. Glantz SA (ed). McGraw-Hill, New York, 1987; p 64.
29. Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli TA, Cierniewski CS. Radioimmunoassay of human platelet beta-thromboglobulin: Different patterns of beta-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 1985; 106: 690.
30. Tuszynski GP, Rothman VL, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood 1988; 72: 109-15.
31. Kowalska MA, Tuszynski GP. Interaction of thrombospondin with platelet glycoproteins GPIa-IIa and GPIIb-IIIa. Biochem J 1993; 295: 725-30.
32. Wachtfogel YT, DeLa Cadena RA, Kunapuli SP, Rick L, Miller M, Schultze RL, Alteri DC, Edgington TS, Colman RW. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem 1994; 269: 19307-12.
33. Gustafson EJ, Schmaier AH, Wachtfogel YT, Kaufman N, Kucich U, Colman RW. Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest 1989; 84: 28-35.
34. Schmaier AH, Kuo A, Lundberg D, Murray S, Cines DB. Expression of high molecular weight kininogen on human umbilical vein endothelial cells. J Biol Chem 1988; 263: 16327-33.
35. Hasan AAK, Cines DB, Herward H, Schmaier AH, Müller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem 1995; 270: 19256-61.
36. Bradford HN, Jameson BA, Adam AA, Wassell RP, Colman, RW. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain. J Biol Chem 1993; 268: 26546-51.
37. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Bzrin J, Kos J, Turk V. An X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 1988; 7: 2593-9.
38. Majack RA, Mildbrandt J, Dixit VM. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem 1987; 262: 8821-5.
39. Brittain HA, Eckman JR, Suerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion. Blood 1993; 81: 2137-43.
40. DeLa Cadena RA. Laskin KJ, Pixley RA, Sartor RB, Schwab JH, Back N, Bedi GS, Fisher RS. Colman RW. Role of the kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol 1991; 260: G213-9.
41. DeLa Cadena RA. Suffredini A, Page JD, Pixley RA, Kaufman N, Parillo JE, Colman RW. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993; 81: 3313-7.
42. Selim TE, Ghoneim HR, Uknis AB, Colman RW, DeLa Cadena RA. High-and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin. Eur J Biochem 1997; in press.
43. Puri RN, Hu C-J, Colman RW. Cathepsin-G mediated responses in washed platelets are inhibited by high molecular weight kininogen (HK): A novel regulatory function of kininogen. Blood 1991; 76: 144a.
44. Hogg PJ. Thrombospondin 1 as an enzyme inhibitor. Thromb Haemost 1994; 72: 787-92.
45. Humphries JE, DeLa Cadena RA, Atkins TL, Colman RW, Gonias SL. Interaction of high molecular weight kininogen with plasminogen inhibits binding of plasminogen to cell surfaces. Fibrinolysis 1994; 8: 245-54.
46. Bradford HN, DeLa Cadena RA, Kunapuli SP, Dong J-F, Lopez JA, Colman RW. Human kininogens regulate thrombin binding to platelets through the GPIb-IX-V complex. Blood 1997; 90: 1508-19.